Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.
- DOI
- 10.1007/s12325-026-03630-3
- Published
- 2026 Sep
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03630-3,
title = {Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.},
author = {Cutler AJ and Lemyre A and Zhang Q and Mao C and Totev TI and Gauthier-Loiselle M and Wu Y and Liu J and Hashim M and Namjoshi M and Sheehan JJ and Pilon D and Lefebvre P and Khoury ACE and Citrome L},
year = {2026},
journal = {Advances in therapy},
doi = {10.1007/s12325-026-03630-3},
url = {https://doi.org/10.1007/s12325-026-03630-3}
}RIS
TY - JOUR TI - Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis. AU - Cutler AJ AU - Lemyre A AU - Zhang Q AU - Mao C AU - Totev TI AU - Gauthier-Loiselle M AU - Wu Y AU - Liu J AU - Hashim M AU - Namjoshi M AU - Sheehan JJ AU - Pilon D AU - Lefebvre P AU - Khoury ACE AU - Citrome L PY - 2026 JO - Advances in therapy DO - 10.1007/s12325-026-03630-3 UR - https://doi.org/10.1007/s12325-026-03630-3 ER -
APA
AJ, C., A, L., Q, Z., C, M., TI, T., M, G., Y, W., J, L., M, H., M, N., JJ, S., D, P., P, L., ACE, K., & L, C. (2026). Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.. Advances in therapy. https://doi.org/10.1007/s12325-026-03630-3
Source records
- pubmed · retrieved 2026-09-25T09:15:11.046Z